Sicor, one of two legal entities of the Italian business unit of TAPI, operates two production sites in Northern Italy, with the Santhià site situated midway on the highway between Milan and Torino.
Sicor’s plants provide a global platform for the manufacture and marketing of APIs for injectable, inhalation, topical and nasal products. These s...
Sicor, one of two legal entities of the Italian business unit of TAPI, operates two production sites in Northern Italy, with the Santhià site situated midway on the highway between Milan and Torino.
Sicor’s plants provide a global platform for the manufacture and marketing of APIs for injectable, inhalation, topical and nasal products. These specialized plants possess a high level of expertise in the production of steroids, hormones and cytotoxic products. Sicor produces about 60 active ingredients and offers one of the widest ranges of anti-cancer drugs on the market today. The product line also includes anti-inflammatories and muscle relaxants.
The Santhià site has accumulated extensive experience and proven expertise in the production and handling of high-potent compounds (OHC 4, 5 and 6), as well as in contract manufacturing projects. The site maintains dedicated facilities for the production of hormonal compounds, enabling a future growth path within this medication class. The site is regularly audited by leading regulatory agencies (including the FDA, EMA/MHRA and HALMED) and TAPI’s business partners. Sicor Soc Italiana Corticosteroidi Srl engages in production of active pharmaceutical ingredients (API). The company is based in Milan, Italy. Sicor Soc Italiana Corticosteroidi Srl operates as a subsidiary of Teva Pharmaceutical Industries Ltd.
Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 empl...
Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.